Show simple item record

dc.contributor.authorGranado Casas, Minerva
dc.contributor.authorMartínez Alonso, Montserrat
dc.contributor.authorAlcubierre Calvo, Núria
dc.contributor.authorRamírez-Morros, Anna
dc.contributor.authorHernández, Marta
dc.contributor.authorCastelblanco Echavarría, Esmeralda
dc.contributor.authorTorres Puig-gros, Joan
dc.contributor.authorMauricio Puente, Dídac
dc.description.abstractObjectives. Our main aim was to assess the quality of life (QoL) and treatment satisfaction (TS) of subjects with LADA (latent autoimmune diabetes of the adult) and compare these measures with those of patients with other diabetes types, i.e., type 1 (T1DM) and type 2 diabetes mellitus (T2DM). Methods. This was a cross-sectional study with a total of 48 patients with LADA, 297 patients with T2DM and 124 with T1DM. The Audit of Diabetes-Dependent Quality of Life (ADDQoL-19) questionnaire and the Diabetes Treatment Satisfaction Questionnaire (DTSQ) were administered. Relevant clinical variables were also assessed. The data analysis included comparisons between groups and multivariate linear models. Results. The LADA patients presented lower diabetes-specific QoL (p D 0:045) and average weighted impact scores (p D 0:007) than the T2DM patients. The subgroup of LADA patients with diabetic retinopathy (DR) who were treated with insulin had a lowerADDQoLaverage weighted impact score than the other diabetic groups. Although the overall measure of TS was not different between the LADA and T2DM (pD0:389) and T1DM (pD0:091) groups, the patients with LADA showed a poorer hyperglycemic frequency perception than the T2DM patients (p<0:001) and an improved frequency of hypoglycemic perception compared with the T1DM patients (pD0:021). Conclusions. The current findings suggest a poorer quality of life, especially in terms of DRand insulin treatment, among patients with LADA compared with those withT1DM and T2DM. Hyperglycemia frequency perception was also poorer in the LADA patients than in the T1DM and T2DM patients. Further research with prospective studies and a large number of patients is necessary.
dc.description.sponsorshipThis study was supported by grant PS09/01035 and PI12/00183 from the Instituto de Salud Carlos III, Ministry of Economy and Competitiveness, Spain. CIBERDEM is an initiative from Instituto de Salud Carlos III (Plan Nacional de I+D+I and Fondo Europeo de Desarrollo Regional). MGC holds a predoctoral fellowship from the Ministerio de Educación, Cultura y Deporte (FPU15/03005).
dc.relation.isformatofReproducció del document publicat a:
dc.relation.ispartofPeerj, 2017, 5:e3928
dc.rightscc-by (c) Granado Casas, Minerva et al., 2017
dc.subject.classificationQualitat de vida
dc.subject.otherQuality of life
dc.titleDecreased quality of live and treatment satisfaction in patients with latent autoinmune diabetes of the adult

Files in this item


This item appears in the following Collection(s)

Show simple item record

cc-by (c) Granado Casas, Minerva et al., 2017
Except where otherwise noted, this item's license is described as cc-by (c) Granado Casas, Minerva et al., 2017